Our study’s most frequently mutated oncogenes were MUC16, FLNA, MUC4, FAT3, SETD2, and CALR, all of which were pan-cancer driver genes, and no highly mutated lung cancer driver gene ranked in the top 20 mutations, such as EGFR, KRAS, and TP53. This evidence concerns the gene TP53 and lung carcinoma.